Education
About Us
Working with TipRanks
Follow Us
Tectonic Therapeutic Inc (TECX)
NASDAQ:TECX
Total Valuation
Tectonic Therapeutic has a market cap or net worth of $431.86M. The enterprise value is $177.95M.
Market Cap$431.86M
Enterprise Value$177.95M
Share Statistics
Tectonic Therapeutic has 18,776,627 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,776,627
Owned by Insiders38.62%
Owned by Institutions6.65%
Financial Efficiency
Tectonic Therapeutic’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -33.27%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-33.27%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee0.00
Profits Per Employee-1.45M
Employee Count51
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tectonic Therapeutic is ―. Tectonic Therapeutic’s PEG ratio is -1.69.
PE Ratio―
PS Ratio0.00
PB Ratio1.52
Price to Fair Value1.52
Price to FCF-6.34
Price to Operating Cash Flow-7.01
PEG Ratio-1.69
Income Statement
In the last 12 months, Tectonic Therapeutic had revenue of 0.00 and earned -74.15M in profits. Earnings per share was -4.05.
Revenue0.00
Gross Profit0.00
Operating Income-84.04M
Pretax Income-72.92M
Net Income-74.15M
EBITDA-71.48M
Earnings Per Share (EPS)-4.05
Cash Flow
In the last 12 months, operating cash flow was -60.08M and capital expenditures -262.00K, giving a free cash flow of -60.34M billion.
Operating Cash Flow-60.08M
Free Cash Flow-60.34M
Free Cash Flow per Share-3.21
Dividends & Yields
Tectonic Therapeutic pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.56
52-Week Price Change-0.56%
50-Day Moving Average21.06
200-Day Moving Average20.27
Relative Strength Index (RSI)56.02
Average Volume (3m)446.92K
Important Dates
Tectonic Therapeutic upcoming earnings date is May 7, 2026, TBA (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Tectonic Therapeutic as a current ratio of 26.63, with Debt / Equity ratio of 0.51%
Current Ratio26.63
Quick Ratio26.63
Debt to Market Cap<0.01
Net Debt to EBITDA3.53
Interest Coverage Ratio-1.33K
Taxes
In the past 12 months, Tectonic Therapeutic has paid 1.23M in taxes.
Income Tax1.23M
Effective Tax Rate-0.02
Enterprise Valuation
Tectonic Therapeutic EV to EBITDA ratio is -1.81, with an EV/FCF ratio of -2.15.
EV to Sales0.00
EV to EBITDA-1.81
EV to Free Cash Flow-2.15
EV to Operating Cash Flow-2.16
Balance Sheet
Tectonic Therapeutic has $253.80M in cash and marketable securities with $1.28M in debt, giving a net cash position of $252.52M billion.
Cash & Marketable Securities$253.80M
Total Debt$1.28M
Net Cash$252.52M
Net Cash Per Share$13.45
Tangible Book Value Per Share$13.72
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tectonic Therapeutic is $91.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$91.33
Price Target Upside281.65% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast60.40%